Not logged in Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial Gogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik Share Save
PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC) Abraham, Jean E.; Pinilla, Karen; Grybowicz, Louise; Dayimu, Alimu; Demiris, Nikolaos; Harvey, Caron; Drewett, Lynsey M.; Lucey, Rebecca; Fulton, Alexander; Roberts, Anne N.; Worley, Joanna R.; Chhabra, Anita; Qian, Wendi; Hardy, Richard M.; Chan, Stephen; Hickish, Tamas; Tripathi, Devashish; Venkitaraman, Ramachandran; Persic, Mojca; Aslam, Shahzeena; Glassman, Daniel; Raj, Sanjay; Borley, Annabel; Braybrooke, Jeremy P.; Sutherland, Stephanie; Staples, Emma; Scott, Lucy C.; Davies, Mark; Palmer, Cheryl A.; Moody, Margaret; Churn, Mark J.; Newby, Jacqueline C.; Mukesh, B. Mukesh; Chakrabarti, Amitabha; Roylance, Rebecca R.; Schouten, Philip C.; Levitt, Nicola; McAdam, Karen; Armstrong, Anne C.; Copson, Ellen R.; McMurtry, Emma; Tischkowitz, Marc; Provenzano, Elena; Earl, Helena Share Save
Tracking triple negative breast cancer (TNBC) evolution in the molecular residual disease (MRD) setting in the c-TRAK TN clinical trial Coakley, Maria; Cutts, Rosalind J.; Sritharan, Prithika; Hrebien, Sarah; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Villacampa, Guillermo; Rojas, Patricia; Emmett, Warren; Pipinikas, Christodoulos; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Bliss, Judith M.; Garcia-Murillas, Isaac; Turner, Nicholas C. Share Save
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node plus ve, hormone receptor+ve, HER2-ve breast cancer Holt, Simon; Verrill, Mark; Pettit, Laura; Rigg, Anna; Hickish, Tamas; Archer, Caroline; Dent, Jo; Dillon, Marianne; Nathan, Mark; Barthelmes, Ludger; Rehman, Shazza; Sharaiha, Yousef; Innis, Paige; Sai-Giridhar, Priya; Khawaja, Saira Share Save
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer Coakley, Maria; Villacampa, Guillermo; Sritharan, Prithika; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Pipinikas, Christodoulos; Rojas, Patricia; Emmett, Warren; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Palmieri, Carlo; Winter, Matthew; Cutts, Rosalind J.; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas C. Share Save
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010) Ring, Alistair; Kilburn, Lucy S.; Pearson, Alex; Moretti, Laura; Afshari-Mehr, Angelica; Wardley, Andrew M.; Gurel, Bora; Macpherson, Iain R.; Riisnaes, Ruth; Baird, Richard D.; Martin, Sue; Roylance, Rebecca; Johnson, Hannah; Ferreira, Ana; Winter, Matthew C.; Dunne, Kathryn; Copson, Ellen; Hickish, Tamas; Burcombe, Russell; Randle, Kat; Serra, Violeta; Llop-Guevara, Alba; Bliss, Judith M.; Turner, Nicolas C. Share Save
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the use of Oncotype DX® to guide chemotherapy in 680 women with hormone receptor positive, HER2 negative breast cancer and 1 to 3 nodes involved Holt, Simon D.; Sai-Giridhar, Priyadharshini; Verrill, Mark; Pettit, Laura; Rigg, Anna; Hickish, Tamas; Archer, Caroline D.; Wadhawan, Anshu; Dillon, Marianne; Dent, Jo; Nathan, Mark R.; Barthelmes, Ludger; Rehman, Shazza; Innis, Paige; Khawaja, Saira Share Save
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial Coakley, Maria; Sritharan, Prithika; Villacampa, Guillermo; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Rojas, Patricia; Joad, Andy; Emmett, Warren; Knape, Charlene; Howarth, Karen; Hall, Peter S.; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia F.; Wardley, Andrew M.; Wheatley, Duncan; Waters, Simon; Cutts, Rosalind; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas Share Save
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer Turner, N. C.; Swift, C.; Jenkins, B.; Kilburn, L.; Coakley, M.; Beaney, M.; Fox, L.; Goddard, K.; Garcia-Murillas, I.; Proszek, P.; Hall, P.; Harper-Wynne, C.; Hickish, T.; Kernaghan, S.; Macpherson, I. R.; Okines, A. F. C.; Palmieri, C.; Perry, S.; Randle, K.; Snowdon, C.; Stobart, H.; Wardley, A. M.; Wheatley, D.; Waters, S.; Winter, M. C.; Hubank, M.; Allen, S. D.; Bliss, J. M. Share Save
Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer Turner, Nicholas; Swift, Claire; Jenkins, Ben; Kilburn, Lucy; Coakley, Maria; Beaney, Matthew; Fox, Lisa; Goddard, Katie; Garcia-Murillas, Isaac; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Kernaghan, Sarah; Macpherson, Iain; Okines, Alicia; Palmieri, Carlo; Perry, Sophie; Randle, Katrina; Snowdon, Claire; Stobart, Hilary; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Winter, Matthew; Bliss, Judith Share Save
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial Hickish, Tamas; Mehta, Ajay; Liu, Mei-Ching; Huang, Chiun-Sheng; Arora, Rajendra Singh; Chang, Yuan-Ching; Yang, Youngsen; Vladimirov, Vladimir; Jain, Minish; Tsang, Janice; Pemberton, Karine; Sadrolhefazi, Behbood; Jin, Xidong; Tseng, Ling-Ming Share Save
Vandetanib plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER positive breast cancer (FURVA): A randomised, double-blind, placebo-controlled, phase II trial Jones, R.; Casbard, A.; Carucci, M.; Smith, J.; Ingarfield, K.; Gee, J. M. W.; Hudson, Z.; Alchami, F.; Hayward, L.; Hickish, T.; Hwang, D.; McAdam, K.; Spensley, S.; Waters, S.; Wheatley, D.; Beresford, M. Share Save
Share Save
Impact of the Oncotype DX breast cancer assay on treatment decisions in a UK population of patients with oestrogen receptor positive early breast cancer with 1-3 lymph nodes positive who are candidates for chemotherapy, but for whom the benefits are uncertain - Interim results Thomas, Daniel; Maxwell, William; Archer, Caroline; Rigg, Anne; Hickish, Tamas; Dent, Jo; Pettit, Laura; Dillon, Marianne; Goldsmith, Christy; Verrill, Mark; Barthelmes, Ludger; Khawaja, Saira; Sharaiha, Yousef; Davies, Mark; Arikat, Fawaz; Khan, Sahail; Munir, Asma; Huws, Anita; Holt, Simon DavidHenry Share Save
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT Ivesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose; Saunders, Mark P.; Briggso, Andrew H.; Cassidyo, Jim; Hollandero, Niels Henrik; Taberneroo, Josep; Haydon, Andrew; Glimeliuso, Bengt; Harkino, Andrea; Allano, Karen; McQueeno, John; Pearsono, Sarah; Waterstono, Ashita; Medleyo, Louise; Wilsono, Charles; Elliso, Richard; Essapen, Sharadah; Dhaddao, Amandeep S.; Harrison, Mark; Falko, Stephen; Raoufo, Sherif; Rees, Charlotte; Oleseno, Rene K.; Proppero, David; Bridgewatero, John; Azzabio, Ashraf; Farrugiao, David; Webbo, Andrew; Cunninghamo, David; Hickish, Tamas; Weavero, Andrew; Gollins, Simon; Wasano, Harpreet; Paulo, James Share Save
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer Huober, Jens; Holmes, Eileen; Baselga, Jose; de Azambuja, Evandro; Untch, Michael; Fumagalli, Debora; Sarp, Severine; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Lecocq, Christophe; Wildiers, Hans; Jouannaud, Christelle; Hackman, John; Dasappa, Lokanatha; Ciruelos, Eva; Toral Pena, Juan Carlos; Adamchuk, Hryhoriy; Hickish, Tamas; de la Pena, Lorena; Jackisch, Christian; Gelber, Richard D.; Piccart-Gebhart, Martine; Di Cosimo, Serena Share Save
Share Save
Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Post hoc Analysis of the MOSAIC and PETACC-8 Trials Auclin, Edouard; Taieb, Julien; Lepage, Come; Aparicio, Thomas; Faroux, Roger; Mini, Enrico; Folprecht, Gunnar; Salazar, Ramon; Benetkiewicz, Magdalena; Banzi, Maria; Louvet, Christophe; Van Laethem, Jean-Luc; Tabernero, Josep; Hickish, Tamas; de Gramont, Aimery; Andre, Thierry; Vernerey, Dewi Share Save
Share Save
Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer Kurzrock, Razelle; Hickish, Tamas; Wyrwicz, Lucjan; Saunders, Mark; Wu, Qian; Stecher, Michael; Mohanty, Prasant; Dinarello, Charles A.; Simard, John Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
CANCER RESEARCH.png)
.png){kind=icon}
Share.png){kind=icon}
Save